Page last updated: 2024-10-31

midazolam and Local Neoplasm Recurrence

midazolam has been researched along with Local Neoplasm Recurrence in 2 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gargiulo, M1
Cortese, A1
Pantaleo, G1
Parascandalo, S1
Amato, M1
Sessler, DI1
Ben-Eliyahu, S1
Mascha, EJ1
Parat, MO1
Buggy, DJ1

Trials

1 trial available for midazolam and Local Neoplasm Recurrence

ArticleYear
Can regional analgesia reduce the risk of recurrence after breast cancer? Methodology of a multicenter randomized trial.
    Contemporary clinical trials, 2008, Volume: 29, Issue:4

    Topics: Analgesics, Opioid; Anesthesia, Conduction; Anesthesia, General; Breast Neoplasms; Female; Fentanyl;

2008

Other Studies

1 other study available for midazolam and Local Neoplasm Recurrence

ArticleYear
A relapsed lower-lip squamous cell carcinoma treated with curative electrochemotherapy in an elderly patient.
    Minerva stomatologica, 2018, Volume: 67, Issue:1

    Topics: Airway Obstruction; Analgesics, Opioid; Antibiotics, Antineoplastic; Bleomycin; Carcinoma, Squamous

2018